₹504.30-8.70 (-1.70%)
04:01 PM, 6-Jan-2026₹502.30-10.90 (-2.12%)
03:49 PM, 6-Jan-2026BSE : 543064
NSE : COHANCE
Sector : Health care
ISIN Code : INE03QK01018
Last Updated: 06-Jan-2026 | 04:01 PM IST
| Market Cap (₹ Cr) | 19,295 |
Traded Value (₹ Cr) | 0.33 |
Volume (Shares) | 6,577 |
Face Value (₹) | 1 |
52-Week High (₹) | 1,328.20 |
52-Week High Date | 20-Feb-2025 |
52-Week Low (₹) | 500.90 |
52-Week Low Date | 06-Jan-2026 |
All Time High (₹) | 1,359.00 |
All Time High Date | 02-Dec-2024 |
All Time Low (₹) | 87.05 |
All Time Low Date | 24-Mar-2020 |
| PARAMETER | VALUES |
|---|---|
| Market Cap (₹ Cr) | 19,218 |
| EPS - TTM (₹) [C] | 8.19 |
| P/E Ratio (X) [C] | 61.33 |
| Face Value (₹) | 1 |
| Latest Dividend (%) | 100.00 |
| Latest Dividend Date | 09-Sep-2022 |
| Dividend Yield (%) | - |
| Book Value Share (₹) [C] | 99.01 |
| P/B Ratio (₹) [C] | 5.07 |
| Scheme Name | Amount Invested (₹ Cr) | No Of Shares | Net Asset (%) |
|---|---|---|---|
| UTI-Flexi Cap Fund (IDCW) | 107.31 | 20,30,000 | 0.43 |
| UTI-Flexi Cap Fund (G) | 107.31 | 20,30,000 | 0.43 |
| UTI-Flexi Cap Fund - Direct (G) | 107.31 | 20,30,000 | 0.43 |
| UTI-Flexi Cap Fund - Direct (IDCW) | 107.31 | 20,30,000 | 0.43 |
| UTI-Healthcare Fund (IDCW) | 20.36 | 3,85,137 | 1.85 |
| UTI-Healthcare Fund (G) | 20.36 | 3,85,137 | 1.85 |
| UTI-Healthcare Fund - Direct (G) | 20.36 | 3,85,137 | 1.85 |
| UTI-Healthcare Fund - Direct (IDCW) | 20.36 | 3,85,137 | 1.85 |
| UTI-Unit Linked Insurance Plan | 8.82 | 1,66,869 | 0.17 |
| UTI-Unit Linked Insurance Plan - Direct | 8.82 | 1,66,869 | 0.17 |
Load more
| Today's Low/High (₹) | 499.70 513.00 |
| Week Low/High (₹) | 499.70 535.00 |
| Month Low/High (₹) | 499.70 549.00 |
| Year Low/High (₹) | 499.70 1,328.00 |
| All time Low/High (₹) | 87.05 1,360.00 |
| Period | BSE | NSE | SENSEX | NIFTY |
|---|---|---|---|---|
| 1 Week | -4.81% | -4.78% | 0.46% | 0.92% |
| 1 Month | -7.36% | -7.42% | -0.76% | -0.03% |
| 3 Month | -42.18% | -42.24% | 4.00% | 4.39% |
| 6 Month | -51.88% | -51.54% | 1.95% | 2.82% |
| 1 Year | -54.01% | -54.03% | 9.10% | 10.85% |
| 3 Year | 1.97% | 1.91% | 42.01% | 46.58% |
Chairman & Exec. Director : Vivek Sharma
Non-Exec & Non-Independent Dir : Vinod Padikkal
Independent Non Exe. Director : K G Ananthakrishnan
Independent Non Exe. Director : Matangi Gowrishankar
Independent Non Exe. Director : Vinod Rao
Independent Non Exe. Director : U B Pravin Rao
Independent Non Exe. Director : Jaishankar Krishnan
Non Executive Director : Pankaj Patwari
Non Executive Director : Shweta Jalan
CS / Compliance Officer / Legal Head : KUNDAN KUMAR JHA
Whole Time Director & Chief Financial Officer : Himanshu Agarwal
Registered Office: 8-2-334 SDE Serene Chambers, 3 Floor Avenue 7 Road No 5,Hyderabad,Telangana-500034 Ph: 91-40-23549414/1142/3311
Email:khrao@suvenpharm.com
1. What's the Cohance Lifesciences Ltd share price today?
Cohance Lifesciences Ltd share price was Rs 504.30 at 04:01 PM IST on 6th Jan 2026. Cohance Lifesciences Ltd share price was down by 1.70% from the previous closing price of Rs 513.00. Cohance Lifesciences Ltd share price trend:
2. How can I quickly analyse the performance of the Cohance Lifesciences Ltd stock?
The performance of the Cohance Lifesciences Ltd stock can be quickly analysed on the following metrics:
3. What is the market cap of Cohance Lifesciences Ltd?
Cohance Lifesciences Ltd has a market capitalisation of Rs 19,295 crore.
4. What is Cohance Lifesciences Ltd's 52-week high/low share price?
The Cohance Lifesciences Ltd’s 52-week high share price is Rs 1,328.20 and 52-week low share price is Rs 500.90.
5. Is the Cohance Lifesciences Ltd profitable?
On a consolidated basis, Cohance Lifesciences Ltd reported a profit of Rs 66.39 crore on a total income of Rs 571.17 crore for the quarter ended 2025.
6. Which are Cohance Lifesciences Ltd’s peers in the Health care sector?
Cohance Lifesciences Ltd’s top 5 peers in the Health care sector are Astrazeneca Phar, OneSource Speci., Sai Life, Cohance Life, Neuland Labs., Jubilant Pharmo, Natco Pharma.
7. Who owns how much in Cohance Lifesciences Ltd?
Key changes to the Cohance Lifesciences Ltd shareholding are as follows: